Sciences, Inc. at 1
emtricitabine (FTC), and tenofovir alafenamide (TAF). The recommended dosage of BIKTARVY is one tablet containing 50 mg of BIC, 200 mg of FTC, and 25 mg of TAF taken orally once daily with or without food in: • adults and pediatric patients weighing at least 25 kg with an estimated creatinine clearance greater than or equal to 30 mL/min; or
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
-800 GILEAD5 or FDA at 1800 FDA 1088 or …
www.gilead.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.gilead.com3 full prescribing information warning: posttreatment acute exacerbation of hepatitis b and risk of drug resistance with use of truvada for hiv-1 pre-
AmBisome (amphotericin B) liposome for injection
www.gilead.com5 Pediatric and Elderly Patients The pharmacokinetics of amphotericin B after administration of AmBisome in pediatric and elderly patients has not been studied; however, AmBisome has
(incidence greater than or equal to 10%, Grades 2
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIREAD safely and effectively. DSee full prescribing information …
Information, Highlights, Prescribing, Prescribing information, Highlights of prescribing information, Viread
for BIKTARVY. BIKTARVY ...
www.gilead.comGilead Sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively.
AMENDED AND RESTATED LICENSE AGREEMENT …
www.gilead.comFinal Version 1 AMENDED AND RESTATED LICENSE AGREEMENT (TEMPLATE) This AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is made as of July __, 2011 (the “Effective Date”) by and between Gilead Sciences, Inc. a
Agreement, Sciences, License, Template, Amended, Restated, Gilead, Gilead sciences, Amended and restated license agreement
HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, …
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, or 6 These highlights do not include all the information needed to use HARVONI ® safely and effectively. See full prescribing information
LETAIRIS for LETAIRIS ...
www.gilead.com2 FULL PRESCRIBING INFORMATION WARNING: EMBRYO-FETAL TOXICITY Do not administer Letairis to a pregnant female because it may cause fetal harm.
MEDICATION GUIDE ZYDELIG (zye-DEL-ig) …
www.gilead.comMEDICATION GUIDE ZYDELIG® (zye-DEL-ig) (idelalisib) tablets What is the most important information I should know about Zydelig? Zydelig can cause serious side effects that can lead to death, including:
Guide, Medication, Medication guide zydelig, Zydelig, Zye del
HIGHLIGHTS OF PRESCRIBING INFORMATION should only be …
www.gilead.com1 INDICATIONS AND USAGE . 1.1 HIV-1 Infection . VIREAD ® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric …
Related documents
Truvada Medication Information Sheet
www.cdc.gov• The 2 medications that make up Truvada (tenofovir and emtricitabine) block important pathways that viruses use to set up infection. • If you take Truvada as PrEP daily, the presence of the medication in your bloodstream can sometimes stop the virus from establishing itself and slow the spread of HIV in your body.
AHFS Pharmacologic-Therapeutic Classification System
www.oregon.govEmtricitabine (303035) lamiVUDine (396011) Stavudine (394033) Tenofovir Alafenamide (316083) Tenofovir Disoproxil Fumarate (301063) Zidovudine (387007) Elvitegravir, Cobicistat, Emtricitabine, and Elvitegravir, Cobicistat, Emtricitabine, and 8:18.08.92 Antiretrovirals, Miscellaneous 8:18.20 Interferons Interferon Alfa (301061) Peginterferon ...
PrEP for HIV Prevention: FAQs
www.cdc.govNov 07, 2019 · Emtricitabine (F) 200 mg in combination with tenofovir disoproxil fumarate (TDF) 300 mg (F/TDF – brand name . Truvada ® or generic equivalent). Emtricitabine (F) 200 mg in combination with tenofovir alafenamide (TAF) 25 mg (F/TAF – brand name . Descovy ®). These medications are approved to prevent HIV infection in adults and
Alberta HIV Pre-Exposure Prophylaxis (PrEP) Guidelines
www.albertahealthservices.caF/TAF (fixed drug combination Tenofovir alafenamide 25 mg / Emtricitabine 200 mg2), one tablet daily (continuous PrEP) is an alternative option for PrEP with equal efficacy. F/TAF was approved in Canada in December 2020 and is not covered under the Alberta HIV PrEP program. F/TAF is not studied for persons at risk for HIV from
Medication Coverage Changes
www.cigna.comJan 01, 2022 · emtricitabine capsule. Pharmacy etravirine 25mg, 100mg, 200mg tablet (AIDS/HIV) Will no longer need approval from Cigna before it can be covered. • Your doctor’s office no longer has to request coverage approval from Cigna. Pharmacy EYLEA (Eye Conditions) Will have a change to its coverage requirements. • This change won’t affect current
HIGHLIGHTS OF PRESCRIBING INFORMATION for DESCOVY. …
www.gilead.comDESCOVY is a two-drug combination of emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated: • in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg.